Results 71 to 80 of about 4,903,989 (176)

Kikuchi-Fujimoto disease and systemic lupus erythematosus

open access: yes, 2016
Diego F Baenas,1 Fernando A Diehl,1 María J Haye Salinas,2 Verónica Riva,3 Ana Diller,3 Pablo A Lemos1,4 1Clinical Medicine Department, 2Rheumatology Department, 3Pathology Department, Hospital Privado Universitario de Córdoba ...
Baenas DF   +5 more
core  

Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis in children: a case-control study

open access: yesBMC Pediatrics
Background This study was performed to summarize the clinical and laboratory features of children with Kikuchi-Fujimoto disease concurrent with aseptic meningitis or encephalitis.
Bing Liu   +6 more
doaj   +1 more source

Genetic Testing Unveils a Novel Thrombospondin‐1 Domain Containing Protein 1 Gene Variant as the Cause of Chronic Edema in a 79‐Year‐Old Woman

open access: yesClinical Genetics, EarlyView.
A 79‐year‐old woman with lifelong peripheral edema and an affected sister was found to harbor a novel homozygous THSD1 splice‐site variant. Reduced THSD1 expression in dermal endothelial cells supported the possibility that this variant contributes to chronic hereditary edema.
Eiko Amo   +23 more
wiley   +1 more source

Ella Kikuchi, 90

open access: yes, 2020
Ella Y. Kikuchi, a teacher who lived at Channing House in Palo Alto, has died. She was 90. Kikuchi, who died on Aug. 12, was Born in Honolulu, Hawaii, on Oct.
Daily Post
core  

Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction‐Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open‐Label Trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Type 2 diabetes drives the progression of metabolic dysfunction‐associated steatohepatitis (MASH). We evaluated whether antidiabetic therapy, specifically adding sodium–glucose cotransporter 2 (SGLT2) inhibitor to a glucagon‐like peptide‐1 receptor agonist (GLP‐1RA), improves liver histology in adults with biopsy‐proven MASH and type 2 ...
Teruki Miyake   +14 more
wiley   +1 more source

Stability and Variability of Symptom Burden in Primary Biliary Cholangitis: Insights From a Decade of Follow‐Up

open access: yesHepatology Research, EarlyView.
Impairment of health‐related quality of life in patients with PBC, in particular observed in younger female, represents distinct dimensions of disease impact, independently of long‐term outcomes. Overall and interindividual changes in PBC‐40 scores greatly varied over 10 years, suggesting that symptom burdens are driven by heterogeneous underlying ...
Akihito Takeuchi   +22 more
wiley   +1 more source

Necrotizing Histiocytic Lymphadenitis: Report of two cases (Kikuchi-Fujimoto disease)

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2004
Kikuchi-Fujimoto disease is a necrotizing Lymphadenitis with benign self-limit process in young women with fever, cervical lymphadenopathy and increased ESR with leukopenia. In this report we introduce 2 females with Kikuchi-Fujimoto disease.
M.Sharbatdaran (MD)   +2 more
doaj  

Heat shock protein 72 attenuates atherosclerosis in apolipoprotein E‐deficient mice

open access: yesJournal of Diabetes Investigation, EarlyView.
Heat shock (HS) + mild electrical stimulation (MES)‐induced heat shock protein (HSP)72 expression prevents atherogenesis in HSP72+/+/ApoE−/− mice. HS + MES‐induced HSP72 expression reduces macrophage infiltration, oxidative stress, JNK activity, and MCP‐1 expression, and alters macrophage polarity from M1 to M2.
Rintaro Yoshizumi   +12 more
wiley   +1 more source

Kikuchi-Fujimoto disease coexisted with Sjogren's syndrome

open access: yes, 2007
Here we described a case of primary Sjogren's syndrome that coexisted with Kikuchi-Fujimoto ...
Peynirci, Hande   +4 more
core   +1 more source

Kikuchi Disease: CT and MR Findings [PDF]

open access: yes, 1997
Two cases of Kikuchi disease showed variable nodal enhancing features, including homogeneous enhancement and focal or extensive nodal necrosis on contrast-enhanced CT scans.
정태섭
core  

Home - About - Disclaimer - Privacy